PI
ONC

PEAK6 Investments’s BeOne Medicines Ltd ONC Stock Holding History

PEAK6 Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,500
Closed -$472K – 6606
2022
Q1 		$472K Buy
+2,500
New +$531K ﹤0.01% 3207
2019
Q4 		– Sell
-4,000
Closed -$490K – 4196
2019
Q3 		$490K Hold
4,000
– – ﹤0.01% 2290
2019
Q2 		$496K Sell
4,000
-1,300
-25% -$165K ﹤0.01% 2271
2019
Q1 		$700K Sell
5,300
-6,100
-54% -$823K ﹤0.01% 2131
2018
Q4 		$1.6M Buy
11,400
+7,000
+159% +$928K 0.01% 1396
2018
Q3 		$758K Buy
+4,400
New +$740K ﹤0.01% 2230

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PEAK6 Investments's ONC Position: Q3 2024 in Review

PEAK6 Investments sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 2,000 shares — an estimated $285K sold.

PEAK6 Investments first reported a position in ONC in Q3 2018 and held it in 9 quarters. The position peaked at $491K in Q3 2018. 227 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • PEAK6 Investments reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2,000 BeOne Medicines Ltd shares in Q3 2024, an estimated $285K.
  • PEAK6 Investments first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 9 quarters.
  • PEAK6 Investments's BeOne Medicines Ltd position peaked at $491K in Q3 2018.
  • 227 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.